Pakistan launches locally manufactured Pak Week corona vaccine

Pakistan launches locally manufactured Pak Week corona vaccine

On Tuesday, Pakistan launched its first locally produced coronavirus vaccine Pak Week with the help of a Chinese company.

Announcing the feat on Tuesday, Federal Minister Asad Omar said Pakistan had prepared the first consignment of 120,000 food for Pak Week, according to 24News HD TV channel.

He confirmed that after the local vaccine was imported into Pakistan, the vaccine of a Chinese private company was made from the raw material of Sino Week.

The Federal Minister further confirmed that Pakistan has the capacity to produce 3 million doses of Pak Vaccine Corona vaccine every month at the local plant. Pakistani health officials have described the development of locally-produced vaccines as an important step in helping Pakistan’s vaccine supply line.

Dr. Noshin, Federal Parliamentary Secretary, National Health Services, said that Pak Week is the first vaccine to be developed in Pakistan.

It is noteworthy that the Economic Co-ordination Committee of the Ministry of Finance has approved a budget of Rs. 20 billion for the purchase of 10 million Corona virus vaccines.

It is pertinent to mention here that the NCOC had already announced to start vaccination of registered 18 Plus from June 3.

“With this initiative, all age groups will be vaccinated against polio.

The World Health Organization (WHO) also approved the Synocode-19 vaccine for emergency use on Tuesday.

The UN health agency has signed up for a two-dose vaccine, which is already in place in several countries around the world.

“The WHO today approved the Sinovac-Corona vicovide 19 vaccine for emergency use,” it said in a statement.

The move assures countries, funders, purchasing agencies and communities that it meets international standards of safety, efficiency and readiness.

According to an AFP count, the Sinovak jaw is already in use in 22 regions of the world.

In addition to China, the countries using SinoWak include Pakistan, Chile, Brazil, Indonesia, Mexico, Thailand and Turkey.

The agency said, “The WHO recommends the use of the vaccine in adults 18 years of age and above, on a two-dose schedule with an interval of two to four weeks.

“The results of the vaccine’s efficacy show that the vaccine prevented symptomatic disease in 51% of the population and prevented hospitalization in severe covid 19 and 100% of the educated population.”


Leave a Reply

Your email address will not be published. Required fields are marked *